echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Gut(IF=32) Zhengzhou University, Mingming, Zhaoming Zhang, et al. found that intestinal flora as a noninvasive diagnostic and prognostic biomarker for natural killer/T-cell lymphoma

    Gut(IF=32) Zhengzhou University, Mingming, Zhaoming Zhang, et al. found that intestinal flora as a noninvasive diagnostic and prognostic biomarker for natural killer/T-cell lymphoma

    • Last Update: 2022-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    iNature

    The "microbiota-gut-lymphoma axis" represents an interesting pathway for microbiota-mediated lymphomagenesis and intervention opportunities, but the significance of gut microbiota in natural killer/T-cell lymphoma (NKTCL) remains a mystery
    .

    On November 8, 2022, Zhang Mingming, Li Zhaoming of Zhengzhou University and Chen Weihua of Huazhong University of Science and Technology jointly published a report entitled "Gut microbiota as non- invasive diagnostic and prognostic biomarkers for natural killer/T- cell lymphoma" online at Gut (IF=32).
    The study suggests that gut microbiota can serve as a noninvasive diagnostic and prognostic biomarker for natural killer/T-cell lymphoma
    .
    The study recruited a discovery cohort that included 30 treatment groups – naïve patients and 20 healthy controls (HCs), and a validation cohort that included 12 patients and 13 HCs
    , respectively.
    The authors performed "shotgun method" metagenomic sequencing on their fecal samples, analyzed their gut metagenomics using mOTUs2 V.
    2.
    5, and trained a patient stratification classifier
    with all species-level classification features using the LASSO algorithm implemented by SIAMCAT.

    The classifier of this study achieved an accuracy of 0.
    868 under the receiver operating characteristic curve (AUROC) on the discovery cohort and 0.
    910 AUROC accuracy on the validation cohort
    .
    To increase the sample size for model training, the authors retrained the LASSO classifier for NKTCL using all samples from both cohorts and achieved an accuracy
    of 0.
    813.
    AUROC cross-validation, which strongly supports the role
    of gut microbiota as a diagnostic biomarker for NKTCL.

    To examine the specificity of NKTCL gut microbiota-derived features, the authors applied a whole-sample NKTCL classifier to 29 cohorts
    of public gut microbiota.
    The authors observed an overall false-positive rate (FPR) of 3.
    1% for HC, but higher FPR in patients with several cohorts, particularly pancreatic cancer, Crohn's disease, and liver disease
    .
    These results imply a significant overlap of biomarkers between these diseases and NKTCL, which was confirmed by LEfSe analysis
    .
    Importantly, these biomarkers were consistently enriched/decreased in most cohorts, including the enrichment of oral-derived Veillonella and Streptococcus in patients, as well as known beneficial species in HCs, such as Faecalibacterium prausnitzii, Eubacterium rectale and Bifidobacte-rium adolescentis
    。 These results suggest that the authors' classifier can accurately distinguish NKTCL patients from HCs;
    However, since there are biomarkers that are shared with other diseases, combining selected clinical indicators with microbiota biomarkers will help establish unique diagnostic models
    .
    The results of the relevant data (image from Gut) found that survival data for NKTCL patients in the cohort were available
    .
    Of note, many identified biota biomarkers, particularly those shared by multiple diseases, can significantly predict overall survival (OS) and progression-free survival (PFS) in patients, including Streptococcus paraserpentineus, timmonensis, and Dyspores (Figures 1A-D
    on Supplement).
    。 Finally, the authors established the Streptococcus parasanguinis, Romboutsia timonensis, and Veillonella atypica index (SRI) as the relative abundance ratios of the two species, yielding the best predictive power
    than other individual species and combinations.
    That is, patients with NKTCL with higher SRI scores had significantly lower OS and PFS than patients with
    lower SRI scores.
    In addition, the authors observed a significant correlation
    between high SRI scores and multiple adverse prognostic factors for NKTCL.
    In conclusion, the results of this study support the use of intestinal flora as an effective auxiliary diagnostic tool
    for NKTCL.
    In addition, SRI scores based on shared biomarkers may have broad utility in the prognosis of multiple diseases and warrant further investigation
    .
    Original link: https://gut.
    bmj.
    com/content/early/2022/11/08/gutjnl-2022-328256?rss=1
    ENDthe content is [iNature].

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.